TB deaths rank alongside HIV deaths as top infectious killer

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 2, 2016, Pages 143-144

  Glaziou, Philippe ^a   Floyd, Katherine ^a   Weil, Diana ^a   Raviglione, Mario ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH; DISEASE ASSOCIATION; EDITORIAL; EPIDEMIC; FUNDING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; CAUSE OF DEATH; ECONOMICS; GLOBAL HEALTH; HIV INFECTIONS; INCIDENCE; MICROBIOLOGY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; VIROLOGY;

CAUSE OF DEATH; GLOBAL HEALTH; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; INCIDENCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUBERCULOSIS;

EID: 84954423892     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0985     Document Type: Editorial

References (10)

1. World Health Organization. Global Tuberculosis Report 2015. WHO/HTM/TB/2015.22. Geneva, Switzerland: WHO, 2015.
2. Joint United Nations Programme on HIV/AIDS. How AIDS changed everything. Geneva, Switzerland: UNAIDS, 2015.
3. Korenromp E.L., Bierrenbach A L, Williams B G, Dye C. The measurement and estimation of tuberculosis mortality. [State of the Art] Int J Tuberc Lung Dis 2009; 13: 283-303.
4. Tiemersma E.W., van der Werf M J, Borgdorff M W, Williams B G, Nagelkerke N J D. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLOS ONE 2011; 6(4): e17601.
5. Munayco CV, Mújica O J, León F X, del Granado M, Espinal M A. Social determinants and inequalities in tuberculosis incidence in Latin American and Caribbean countries. Rev Panam Salud Publica 2015; 38(3).
6. Joint United Nations Programme on HIV/AIDS. Financing the response to HIV in low and middle-income countries. Geneva, Switzerland: UNAIDS, 2015.
7. Floyd K, Fitzpatrick C, Pantoja A., Raviglione M. Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-2011, and requirements to meet 2015 targets. The Lancet Global Health 2013; 1(2): e105-115.
8. Vassall A. Benefits and costs of the tuberculosis targets for the post-2015 development agenda. Health Tuberculosis Perspective paper. Copenhagen, Denmark: Copenhagen Consensus Center, 2014. http://www.copenhagenconsensus.com/sites/default/files/health-perspective-tb-vassall.pdf Accessed December 2015.
9. Uplekar M, Weil D, Lönnroth K, et al. WHO's new end TB strategy. Lancet 2015; 385: 1799-1801.
10. De Jongh T E, Harnmeijer J H, Atun R, et al. Health impact of external funding for HIV, tuberculosis and malaria: systematic review. Health Policy Plan 2014; 29(5): 650-662.